DEPO-PROVERA

Depo-Provera: A Long-Acting Reversible Contraceptive

Depo-Provera is a contraceptive injection that provides long-term, reversible protection against pregnancy. It is a progestin-only birth control option, given as a shot once every 12 weeks. It is a safe and effective form of contraception that has been used by millions of women worldwide since its introduction in the early 1960s (Danaei et al., 2017).

Depo-Provera works primarily by suppressing ovulation and thickening cervical mucus to prevent sperm from entering the uterus. It is 99% effective at preventing pregnancy and is highly reversible, with fertility returning to normal within three months of ceasing use (World Health Organization, 2019). The injection is administered by a health care professional and lasts for 12 weeks, after which time another injection is needed for continued protection.

Depo-Provera is an ideal contraceptive option for women who have difficulty remembering to take a pill every day, and it is also suitable for those who cannot use estrogen-containing contraceptives or who have medical conditions that would make them a poor candidate for other forms of contraception. It is also a good choice for women who want a long-term, reversible form of birth control.

Depo-Provera is generally safe and well-tolerated, though it can have some side effects such as irregular menstrual bleeding, weight gain, and headaches (World Health Organization, 2019). It is important for women to talk to their healthcare provider about the potential risks and benefits of this contraceptive before deciding to use it.

In conclusion, Depo-Provera is a safe and effective long-acting reversible contraceptive that provides reliable protection against unintended pregnancy. It is an ideal choice for women who need a reliable and reversible form of birth control, and it can be administered easily and conveniently by a healthcare professional.

References

Danaei, M., Shafii, M., Pourabdian, S., & Ahmadvand, A. (2017). Contraceptive efficacy of depot medroxyprogesterone acetate (DMPA): A systematic review and meta-analysis. International Journal of Reproductive BioMedicine, 15(4), 225-234.

World Health Organization. (2019). Contraceptive injections. Retrieved from https://www.who.int/reproductivehealth/contraception/injectables/en/

Scroll to Top